יתרות מזומנים בחישוב למניה PolyPid (PYPD)

PolyPid Limited - לוגו גרפי של המנפיק PYPD

PolyPid Ltd. relies on clinical prospects as it awaits the completion of trials for new drugs. The cash position per share reflects current liquidity dynamics, where the parameter value equals 0.74. High efficiency is driven by an automated Israeli plant. Furthermore, the business possesses benchmark scalability potential, allowing it to generate colossal profits at low costs once the drugs are patented.

PYPD (PolyPid Ltd) היסטוריית יתרות מזומנים למניה מ-04.07.2022 עד 20.11.2026

פילוחים אנליטיים של חברת PolyPid Ltd (PYPD)

- מחיר נוכחי ושווי מניות חזוי:
- מדדי זמינות כספים ותזרימי מזומנים:
ניתוח מקיף של החברה:PolyPid (PYPD)
פריט של המותג PolyPid

The metric is calculated as the difference between net cash and total liabilities, divided by the number of shares. This metric determines the business's financial autonomy and its capacity for self-development without equity dilution. For PolyPid Ltd. (PYPD), this is critical during the commercialization of the D-PLEX drug and preparations for its market launch. The cash per share trend on GURU.Markets demonstrates the company's margin of safety before it reaches the stage of stable revenue.